C. Leong, Antidepressants for Depression in Patients with Dementia: A Review of the Literature, The Consultant Pharmacist, vol.29, issue.4, pp.254-263, 2014.
DOI : 10.4140/TCP.n.2014.254

C. Arbus, V. Gardette, E. Bui, C. Cantet, S. Andrieu et al., Antidepressant use in Alzheimer's disease patients: results of the REAL.FR cohort, International Psychogeriatrics, vol.9, issue.01, pp.120-128, 2010.
DOI : 10.1046/j.1532-5415.2001.49009.x

I. Van-asch, J. Nuyen, M. Veerbeek, D. Frijters, W. Achterberg et al., The diagnosis of depression and use of antidepressants in nursing home residents with and without dementia, International Journal of Geriatric Psychiatry, vol.22, issue.7, pp.312-318, 2013.
DOI : 10.1002/gps.3830

S. Bonin-guillaume, G. Martin, J. Zafack, G. Gentile, V. Allaria-lapierre et al., Consommation d???antipsychotiques chez les sujets atteints de maladie d???Alzheimer et maladies apparent??es de la cohorte PACA-Alz 2010, Th??rapie, vol.69, issue.3, pp.213-222, 2010.
DOI : 10.2515/therapie/2014015

G. Rattinger, M. Burcu, S. Dutcher, P. Chhabra, P. Rosenberg et al., Pharmacotherapeutic Management of Dementia Across Settings of Care, Journal of the American Geriatrics Society, vol.303, issue.5, pp.723-733, 2013.
DOI : 10.1111/jgs.12210

H. Taipale, M. Koponen, A. Tanskanen, A. Tolppanen, J. Tiihonen et al., High prevalence of psychotropic drug use among persons with and without Alzheimer??s disease in Finnish nationwide cohort, European Neuropsychopharmacology, vol.24, issue.11, pp.1729-1737, 2014.
DOI : 10.1016/j.euroneuro.2014.10.004

C. Martinez, R. Jones, and S. Rietbrock, Trends in the prevalence of antipsychotic drug use among patients with Alzheimer's disease and other dementias including those treated with antidementia drugs in the community in the UK: a cohort study, BMJ Open, vol.3, issue.1, pp.438-446, 2013.
DOI : 10.1136/bmjopen-2012-002080

I. Lustenberger, B. Schupbach, A. Von-gunten, and U. Mosimann, Psychotropic medication use in Swiss nursing homes, Swiss Medical Weekly, vol.141, 2011.
DOI : 10.4414/smw.2011.13254
URL : http://doi.org/10.4414/smw.2011.13254

P. Rosenberg, M. Mielke, D. Han, J. Leoutsakos, C. Lyketsos et al., The association of psychotropic medication use with the cognitive, functional, and neuropsychiatric trajectory of Alzheimer's disease, International Journal of Geriatric Psychiatry, vol.59, issue.1, pp.1248-1257, 2012.
DOI : 10.1002/gps.3769

H. Brunnstrom, U. Passant, E. Englund, and L. Gustafson, History of depression prior to Alzheimer's disease and vascular dementia verified post-mortem, Archives of Gerontology and Geriatrics, vol.56, issue.1, pp.80-84, 2013.
DOI : 10.1016/j.archger.2012.10.008

N. Cherbuin, S. Kim, and K. Anstey, Dementia risk estimates associated with measures of depression: a systematic review and meta-analysis, BMJ Open, vol.5, issue.12, p.8853, 2015.
DOI : 10.1136/bmjopen-2015-008853

S. Banerjee, J. Hellier, R. Romeo, M. Dewey, M. Knapp et al., Funding, Health Technology Assessment, vol.17, issue.7, pp.1-166, 2013.
DOI : 10.3310/hta17070

T. Huang, Y. Wei, P. Moyo, I. Harris, and J. Lucas, Treated Behavioral Symptoms and Mortality in Medicare Beneficiaries in Nursing Homes with Alzheimer's Disease and Related Dementias, Journal of the American Geriatrics Society, vol.56, issue.Suppl 1, pp.1757-1765
DOI : 10.1111/jgs.13606

M. Folstein, S. Folstein, and P. Mchugh, ???Mini-mental state???, Journal of Psychiatric Research, vol.12, issue.3, pp.189-198, 1975.
DOI : 10.1016/0022-3956(75)90026-6

L. Duff, F. Develay, A. Quetel, J. Lafay, P. Schuck et al., French National Alzheimer d (2012) The 2008-2012 French Alzheimer plan: description of the national Alzheimer information system, J Alzheimers Dis, vol.29, pp.891-902

Y. Rhee, J. Csernansky, L. Emanuel, C. Chang, and J. Shega, Psychotropic Medication Burden and Factors Associated with Antipsychotic Use: An Analysis of a Population-Based Sample of Community-Dwelling Older Persons with Dementia, Journal of the American Geriatrics Society, vol.170, issue.11, pp.2100-2107, 2011.
DOI : 10.1111/j.1532-5415.2011.03660.x

M. Tartaglia, B. Hu, K. Mehta, J. Neuhaus, K. Yaffe et al., Demographic and Neuropsychiatric Factors Associated With Off-label Medication Use in Frontotemporal Dementia and Alzheimer???s Disease, Alzheimer Disease & Associated Disorders, vol.28, issue.2, pp.182-189, 2014.
DOI : 10.1097/WAD.0b013e3182a7159d

J. Sundquist, T. Hamano, X. Li, N. Kawakami, K. Shiwaku et al., Neighborhood linking social capital as a predictor of psychiatric medication prescription in the elderly: A Swedish national cohort study, Journal of Psychiatric Research, vol.55, pp.44-51, 2014.
DOI : 10.1016/j.jpsychires.2014.04.013

A. Jacquin-piques, G. Sacco, N. Tavassoli, O. Rouaud, Y. Bejot et al., Psychotropic Drug Prescription in Patients with Dementia: Nursing Home Residents Versus Patients Living at Home, Journal of Alzheimer's Disease, vol.49, issue.3, pp.671-680, 2015.
DOI : 10.3233/JAD-150280

D. Maust, K. Langa, F. Blow, and H. Kales, Psychotropic use and associated neuropsychiatric symptoms among patients with dementia in the USA, International Journal of Geriatric Psychiatry, vol.287, issue.(11), 2016.
DOI : 10.1002/gps.4452

A. Marengoni, G. Bianchi, A. Nobili, M. Tettamanti, L. Pasina et al., Prevalence and characteristics of antidepressant drug prescriptions in older Italian patients, International Psychogeriatrics, vol.11, issue.04, pp.606-613
DOI : 10.1002/gps.2483

S. Fereshtehnejad, K. Johnell, and M. Eriksdotter, Anti-Dementia Drugs and Co-Medication Among Patients with Alzheimer???s Disease, Drugs & Aging, vol.16, issue.11, pp.215-224, 2014.
DOI : 10.1007/s40266-014-0154-8

R. Prescrire, Médicaments de la maladie d'Alzheimer : à éviter, Rev Prescrire, vol.32, issue.105, 2012.

V. Desai, P. Heaton, and C. Kelton, Impact of the Food and Drug Administration???s antipsychotic black box warning on psychotropic drug prescribing in elderly patients with dementia in outpatient and office-based settings, Alzheimer's & Dementia, vol.8, issue.5, pp.453-457, 2012.
DOI : 10.1016/j.jalz.2011.08.004

S. Gonfrier, S. Andrieu, D. Renaud, B. Vellas, and P. Robert, Course of neuropsychiatric symptoms during a 4-year follow up in the REAL-FR cohort, The journal of nutrition, health & aging, vol.28, issue.1, p.264345, 2012.
DOI : 10.1007/s12603-011-0147-9

S. Lehmann, M. Schott, J. Rabinovici, G. Rossor, M. Fox et al., Alzheimer's disease, PCA, posterior cortical atrophy; SD, standard deviation * age at first consultation within the BNA network References 1 Crutch Posterior cortical atrophy, Abbreviations: AD, pp.170-178, 2012.

P. Mcmonagle, F. Deering, Y. Berliner, and A. Kertesz, The cognitive profile of posterior cortical atrophy, Neurology, vol.66, issue.3, pp.331-338, 2006.
DOI : 10.1212/01.wnl.0000196477.78548.db

B. Dubois, H. Feldman, and C. Jacova, Revising the definition of Alzheimer's disease: a new lexicon, The Lancet Neurology, vol.9, issue.11, pp.1118-1145, 2010.
DOI : 10.1016/S1474-4422(10)70223-4

S. Crutch, J. Schott, and G. Rabinovici, Shining a light on posterior cortical atrophy, Alzheimer's & Dementia, vol.9, issue.4, pp.463-465, 2013.
DOI : 10.1016/j.jalz.2012.11.004
URL : http://ufdc.ufl.edu/LS00545321/00001

J. Renner, J. Burns, C. Hou, D. Mckeel, . Jr et al., Progressive posterior cortical dysfunction: A clinicopathologic series, Neurology, vol.63, issue.7, pp.1175-1180, 2004.
DOI : 10.1212/01.WNL.0000140290.80962.BF

D. Tang-wai, N. Graff-radford, and B. Boeve, Clinical, genetic, and neuropathologic characteristics of posterior cortical atrophy, Neurology, vol.63, issue.7, pp.1168-1174, 2004.
DOI : 10.1212/01.WNL.0000140289.18472.15

J. Seguin, M. Formaglio, and A. Perret-liaudet, CSF biomarkers in posterior cortical atrophy, Neurology, vol.76, issue.21, pp.1782-1788, 2011.
DOI : 10.1212/WNL.0b013e31821ccc98
URL : https://hal.archives-ouvertes.fr/hal-00965242

E. Coppi, L. Ferrari, and R. Santangelo, Further evidence about the crucial role of CSF biomarkers in diagnosis of posterior cortical atrophy, Neurological Sciences, vol.29, issue.6, pp.785-787, 2014.
DOI : 10.1007/s10072-014-1644-5

L. Souza, F. Corlier, and M. Habert, Similar amyloid-?? burden in posterior cortical atrophy and Alzheimer's disease, Brain, vol.134, issue.7, pp.2036-2043, 2011.
DOI : 10.1093/brain/awr130

E. Beaufils, M. Ribeiro, and E. Vierron, The Pattern of Brain Amyloid Load in Posterior Cortical Atrophy Using (18)F-AV45: Is Amyloid the Principal Actor in the Disease? Dement Geriatr Cogn Dis Extra, pp.431-441, 2014.

A. Kas, L. De-souza, and D. Samri, Neural correlates of cognitive impairment in posterior cortical atrophy, Brain, vol.134, issue.5, pp.1464-1478, 2011.
DOI : 10.1093/brain/awr055

M. Rosenbloom, A. Alkalay, and N. Agarwal, Distinct clinical and metabolic deficits in PCA and AD are not related to amyloid distribution, Neurology, vol.76, issue.21, pp.1789-1796, 2011.
DOI : 10.1212/WNL.0b013e31821cccad

Y. Stern, What is cognitive reserve? Theory and research application of the reserve concept, Journal of the International Neuropsychological Society, vol.8, issue.03, pp.448-460, 2002.
DOI : 10.1017/S1355617702813248

C. Habeck, Q. Razlighi, Y. Gazes, D. Barulli, J. Steffener et al., Cognitive Reserve and Brain Maintenance: Orthogonal Concepts in Theory and Practice, Cerebral Cortex, 2016.
DOI : 10.1093/cercor/bhw208

A. Foubert-samier, G. Catheline, and H. Amieva, Education, occupation, leisure activities, and brain reserve: a population-based study, Neurobiology of Aging, vol.33, issue.2, pp.423-438, 2012.
DOI : 10.1016/j.neurobiolaging.2010.09.023

J. Kim, J. Chey, S. Kim, and H. Kim, The effect of education on regional brain metabolism and its functional connectivity in an aged population utilizing positron emission tomography, Neuroscience Research, vol.94, pp.50-61, 2015.
DOI : 10.1016/j.neures.2014.12.009

P. Rzezak, P. Squarzoni, and F. Duran, Relationship between Brain Age-Related Reduction in Gray Matter and Educational Attainment. PLoS One, p.140945, 2015.
DOI : 10.1371/journal.pone.0140945
URL : http://doi.org/10.1371/journal.pone.0140945

E. Arenaza-urquijo, B. Landeau, L. Joie, and R. , Relationships between years of education and gray matter volume, metabolism and functional connectivity in healthy elders, NeuroImage, vol.83, pp.450-457, 2013.
DOI : 10.1016/j.neuroimage.2013.06.053
URL : https://hal.archives-ouvertes.fr/inserm-00844867

L. Duff, F. Develay, A. Quetel, and J. , French Alzheimer plan: description of the national Alzheimer information system, J Alzheimers Dis, vol.29, issue.4, pp.891-902, 2008.

D. Bennett, R. Wilson, and J. Schneider, Education modifies the relation of AD pathology to level of cognitive function in older persons, Neurology, vol.60, issue.12, pp.1909-1915, 2003.
DOI : 10.1212/01.WNL.0000069923.64550.9F

D. Bennett, J. Schneider, R. Wilson, J. Bienias, and S. Arnold, Education modifies the association of amyloid but not tangles with cognitive function, Neurology, vol.65, issue.6, pp.953-958, 2005.
DOI : 10.1212/01.wnl.0000176286.17192.69

R. Ossenkoppele, D. Schonhaut, and S. Baker, Tau, amyloid, and hypometabolism in a patient with posterior cortical atrophy, Annals of Neurology, vol.70, issue.2, pp.338-342, 2015.
DOI : 10.1002/ana.24321

E. Giacobini and G. Gold, Alzheimer disease therapy???moving from amyloid-?? to tau, Nature Reviews Neurology, vol.8, issue.12, pp.677-686, 2013.
DOI : 10.1016/S0006-291X(84)80190-4

M. Lehmann, J. Barnes, and G. Ridgway, Global gray matter changes in posterior cortical atrophy: A serial imaging study, Alzheimer's & Dementia, vol.8, issue.6, pp.502-514, 2012.
DOI : 10.1016/j.jalz.2011.09.225

A. Aresi and A. Giovagnoli, The Role of Neuropsychology in Distinguishing the Posterior Cortical Atrophy Syndrome and Alzheimer's Disease, Journal of Alzheimer's Disease, vol.18, issue.1, pp.65-70, 2009.
DOI : 10.3233/JAD-2009-1123

V. Isella, G. Villa, and C. Mapelli, The Neuropsychiatric Profile of Posterior Cortical Atrophy, Journal of Geriatric Psychiatry and Neurology, vol.22, issue.4, pp.136-180, 2015.
DOI : 10.1177/0891988714554713

J. Warren, P. Fletcher, and H. Golden, The paradox of syndromic diversity in Alzheimer disease, Nature Reviews Neurology, vol.37, issue.8, pp.451-464, 2012.
DOI : 10.1038/nrneurol.2012.135

E. Sharp and M. Gatz, Relationship Between Education and Dementia, Alzheimer Disease & Associated Disorders, vol.25, issue.4, pp.289-304, 2011.
DOI : 10.1097/WAD.0b013e318211c83c
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3193875

R. Migliaccio, F. Agosta, and K. Rascovsky, Clinical syndromes associated with posterior atrophy: Early age at onset AD spectrum, Neurology, vol.73, issue.19, pp.1571-1578, 2009.
DOI : 10.1212/WNL.0b013e3181c0d427

J. Berkson, Limitations of the Application of Fourfold Table Analysis to Hospital Data, Biometrics Bulletin, vol.2, issue.3, pp.47-53, 1946.
DOI : 10.2307/3002000

M. Mendez, J. Shapira, and D. Clark, ???Apperceptive??? Alexia in Posterior Cortical Atrophy, Cortex, vol.43, issue.2, pp.264-270, 2007.
DOI : 10.1016/S0010-9452(08)70481-7

O. , R. K. Tzourio, C. Dartigues, and J. , Primary and secondary care consultations in elderly demented individuals in France. Results from the Three-City Study, Dement Geriatr Cogn Disord, vol.26, issue.5, pp.407-422, 2008.

P. Gateau, C. Fabrigoule, J. Orgogozo, and J. Dartigues, Dementia in subjects aged 75 years or over within the PAQUID cohort: prevalence and burden by severity, Dement Geriatr Cogn Disord, vol.22, issue.1, pp.87-94, 2006.

C. Elbaz, A. Tzourio, C. Ménard, J. Dartigues, and J. , Joly P 20-Year prevalence projections for dementia and impact of preventive policy about risk factors, Eur J Epidemiol, 2013.

T. Morris, J. Kukull, and W. , NIA Alzheimer's Disease Centers. The National Alzheimer's Coordinating Center (NACC) database: the Uniform Data Set, Alzheimer Dis Assoc Disord

J. Ankri and C. Van-broeckhoven, Evaluation du plan Alzheimer Available from http://social-sante.gouv.fr/IMG/pdf/Rapport-evaluation-plan-alzheimer-2012.pdf 9. Ministère des Affaires sociales, de la Santé et des Droits des femmes. Plan Maladies Neuro-Dégénératives 2014-2019 Available from : http://socialsante .gouv.fr Collection Documents, Plan_maladies_neuro_degeneratives_def.pdf. 10. Haut Conseil de la Santé Publique. Pour une meilleure utilisation des bases de données nationales pour la santé publique et la recherche, 2008.

S. Schneeweiss and J. Avorn, A review of uses of health care utilization databases for epidemiologic research on therapeutics, Journal of Clinical Epidemiology, vol.58, issue.4, pp.323-360, 2005.
DOI : 10.1016/j.jclinepi.2004.10.012

A. Schott, Sensitivity and specificity of two methods used to identify incident breast cancer in specialized units using claims databases. Rev Epidemiol Sante Publique, 2004.
URL : https://hal.archives-ouvertes.fr/hal-00427560

N. Gavrielov-yusim and M. Friger, Use of administrative medical databases in population-based research: Table??1, Journal of Epidemiology and Community Health, vol.32, issue.(4 Pt 1), pp.283-290
DOI : 10.1136/jech-2013-202744

M. Godwin, L. Ruhland, I. Casson, S. Macdonald, D. Delva et al., Pragmatic controlled clinical trials in primary care: the struggle between external and internal validity, BMC Medical Research Methodology, vol.5, issue.3, p.28, 2003.
DOI : 10.1017/S0266462300007406

B. Flay, Efficacy and effectiveness trials (and other phases of research) in the development of health promotion programs Steckler A, McLeroy KR. The importance of external validity, Prev Med. Am J Public Health, vol.1598, issue.181, pp.451-749, 1986.

D. Grimes and K. Schulz, Cohort studies: marching towards outcomes, The Lancet, vol.359, issue.9303, pp.341-346, 2002.
DOI : 10.1016/S0140-6736(02)07500-1

S. Suissa, E. Garbe, and P. Austin, Primer: administrative health databases in observational studies of drug effects--advantages and disadvantages Administrative database research has unique characteristics that can risk biased results, Nat Clin Pract Rheumatol. J Clin Epidemiol, vol.365, issue.122, pp.725-32126, 2007.

L. Duff, F. Develay, A. Quetel, J. Lafay, P. Schück et al., French National Alzheimer dataBank (BNA) The 2008-2012 French Alzheimer plan: description of the national Alzheimer information system, J Alzheimers Dis, vol.29, issue.4, pp.891-902, 2012.

S. Anthony, C. Pradier, R. Chevrier, J. Festraëts, K. Tifratene et al., The French National Alzheimer Database: A Fast Growing Database for Researchers and Clinicians, Dementia and Geriatric Cognitive Disorders, vol.38, issue.5-6, pp.5-6271, 2014.
DOI : 10.1159/000360281

P. Robert, Use of drug treatments for Alzheimer's disease in France: a study on a national level based on the National Alzheimer's Data Bank

M. Kahn, M. Raebel, J. Glanz, K. Riedlinger, and J. Steiner, A Pragmatic Framework for Single-site and Multisite Data Quality Assessment in Electronic Health Record-based Clinical Research, Medical Care, vol.50, pp.21-30, 2012.
DOI : 10.1097/MLR.0b013e318257dd67

C. Whitney, B. Lind, and P. Wahl, Quality Assurance and Quality Control in Longitudinal Studies, Epidemiologic Reviews, vol.20, issue.1, pp.71-80, 1998.
DOI : 10.1093/oxfordjournals.epirev.a017973

K. Vantongelen, N. Rotmensz, and E. Van-der-schueren, Quality control of validity of data collected in clinical trials, European Journal of Cancer and Clinical Oncology, vol.25, issue.8, pp.1241-1248, 1989.
DOI : 10.1016/0277-5379(89)90421-5

D. Arts, D. Keizer, N. Scheffer, and G. , Defining and Improving Data Quality in Medical Registries: A Literature Review, Case Study, and Generic Framework, Journal of the American Medical Informatics Association, vol.9, issue.6, pp.600-611, 2002.
DOI : 10.1197/jamia.M1087

N. Weiskopf and C. Weng, Methods and dimensions of electronic health record data quality assessment: enabling reuse for clinical research, Journal of the American Medical Informatics Association, vol.20, issue.1, pp.144-51, 2013.
DOI : 10.1136/amiajnl-2011-000681

T. Mura, J. Dartigues, and C. Berr, How many dementia cases in France and Europe?
DOI : 10.1111/j.1468-1331.2009.02783.x
URL : https://hal.archives-ouvertes.fr/inserm-00426844

D. Holtzman, W. Jagust, R. Petersen, P. Snyder, M. Carrillo et al., The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease, Alzheimers Dement, vol.7, issue.3, pp.270-279, 2011.

M. Carrillo, B. Thies, S. Weintraub, and C. Phelps, The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease, Alzheimers Dement, vol.7, issue.3, pp.263-272, 2011.

R. Sperling, P. Aisen, L. Beckett, D. Bennett, S. Craft et al., Toward defining the preclinical stages of Alzheimer???s disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease, Alzheimer's & Dementia, vol.7, issue.3
DOI : 10.1016/j.jalz.2011.03.003

P. Visser and P. Scheltens, Revising the definition of Alzheimer's disease: a new lexicon, Lancet Neurol, vol.9, issue.11, pp.1118-1145, 2010.

R. Petersen, B. Caracciolo, C. Brayne, S. Gauthier, V. Jelic et al., Mild cognitive impairment: a concept in evolution, Journal of Internal Medicine, vol.55, issue.3, pp.214-242, 2014.
DOI : 10.1111/joim.12190

R. Petersen, G. Smith, S. Waring, R. Ivnik, E. Tangalos et al., Mild Cognitive Impairment, Archives of Neurology, vol.56, issue.3, pp.303-311, 1999.
DOI : 10.1001/archneur.56.3.303
URL : https://hal.archives-ouvertes.fr/inserm-00112038

H. Brodaty, D. Bennett, H. Chertkow, J. Cummings, M. De-leon et al., International Psychogeriatric Association Expert Conference on mild cognitive impairment

H. Feldman and C. Jacova, Mild Cognitive Impairment, The American Journal of Geriatric Psychiatry, vol.13, issue.8, pp.645-55, 2005.
DOI : 10.1097/00019442-200508000-00003

M. Ganguli, H. Dodge, C. Shen, and S. Dekosky, Mild cognitive impairment, amnestic type: An epidemiologic study, Neurology, vol.63, issue.1, pp.115-136, 2004.
DOI : 10.1212/01.WNL.0000132523.27540.81

R. Ivnik, W. Rocca, R. Petersen, S. Tardiff, C. Dye et al., The incidence of MCI differs by subtype and is higher in men: the Mayo Clinic Study of Aging Rate of conversion from prodromal Alzheimer's disease to Alzheimer's dementia: a systematic review of the literature, Neurology. Dement Geriatr Cogn Dis Extra, vol.783, issue.51, pp.342-51320, 2012.

K. Langa and D. Levine, The Diagnosis and Management of Mild Cognitive Impairment, JAMA, vol.312, issue.23, pp.2551-61, 2014.
DOI : 10.1001/jama.2014.13806

A. Clegg, J. Young, S. Iliffe, M. Rikkert, and K. Rockwood, Frailty in elderly people, The Lancet, vol.381, issue.9868, pp.752-62, 2013.
DOI : 10.1016/S0140-6736(12)62167-9
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4098658

S. Gill, S. Bronskill, S. Normand, G. Anderson, K. Sykora et al., Antipsychotic Drug Use and Mortality in Older Adults with Dementia, Annals of Internal Medicine, vol.146, issue.11, pp.775-86, 2007.
DOI : 10.7326/0003-4819-146-11-200706050-00006

C. Ballard, S. Day, S. Sharp, G. Wing, and S. Sorensen, Neuropsychiatric symptoms in dementia: Importance and treatment considerations, International Review of Psychiatry, vol.48, issue.11, pp.396-404, 2008.
DOI : 10.1212/WNL.55.10.1460

H. Autorité and D. Santé, Maladie d'Alzheimer et maladies apparentées : prise en charge des troubles du comportement perturbateurs, 2009.

H. Autorité and D. Santé, Maladie d'Alzheimer et maladies apparentées : diagnostic et prise en charge Recommandations de bonnes pratiques Available from : http://www.has-sante.fr/portail/upload/docs/application/pdf/2011- 12/recommandation_maladie_d_alzheimer_et_maladies_apparentees_diagnostic_et_prsie_en _charge.pdf 50, 2011.

K. , L. , N. Fourrier-réglat, and A. , Evolution of prevalence of depressive symptoms and antidepressant use between 1988 and 1999 in a large sample of older French people: Results from the personnes agées quid study, J Am Geriatr Soc, vol.54, issue.51, pp.1839-1884, 2006.

C. Chee, J. Deligne, J. Harlin, J. Boddaert, M. Verny et al., Exposure to psychotropics in the French older population living with dementia: a nationwide populationbased study [Epub ahead of print] 52, Int J Geriatr Psychiatry Maust DT, Kim HM, 2016.

A. Foebel, A. Ballokova, A. Wellens, N. Fialova, D. Milisen et al., A retrospective, longitudinal study of factors associated with new antipsychotic medication use among recently admitted long-term care residents, BMC Geriatrics, vol.23, issue.10, pp.438-483, 2015.
DOI : 10.1017/S1041610211001438

X. Thirion and J. Micallef, Antipsychotic use in the cohort PACA-Alz in patients with Alzheimer's disease and other dementia in 2010, Therapie, vol.69, issue.3, pp.213-235, 2014.

R. Group, Antidepressant use in Alzheimer's disease patients: results of the REAL.FR cohort, Int Psychogeriatr, vol.22, issue.1, pp.120-128, 2010.

J. Wastesson, R. Weitoft, G. Johnell, and K. , Educational disparities in antipsychotic drug use among older people with and without dementia in Sweden, Acta Psychiatrica Scandinavica, vol.27, issue.1, pp.20-28, 2015.
DOI : 10.1111/acps.12378

S. Iliffe, L. Robinson, C. Brayne, C. Goodman, G. Rait et al., Primary care and dementia: 1. diagnosis, screening and disclosure, International Journal of Geriatric Psychiatry, vol.22, issue.4, pp.895-901, 2009.
DOI : 10.1002/gps.2204

E. Verhaaren, B. Koudstaal, P. Hofman, A. Ikram, M. Breteler et al., Available from : https://www.alz.co.uk/research/WorldAlzheimerReport2014.pdf 62 Is dementia incidence declining?: Trends in dementia incidence since 1990 in the Rotterdam Study, Alzheimer Disease International World Alzheimer Report 2014, pp.1456-63, 2012.

F. Matthews, A. Arthur, L. Barnes, J. Bond, C. Jagger et al., Medical Research Council Cognitive Function and Ageing Collaboration. A two-decade comparison of prevalence of dementia in individuals aged 65 years and older from three geographical areas of England: results of the Cognitive Function and Ageing Study I and II Twenty-year changes in dementia occurrence suggest decreasing incidence in central, Lancet Neurology, vol.38280, issue.6520, pp.1405-121888, 2013.

L. Robinson, E. Tang, and J. Taylor, Dementia: timely diagnosis and early intervention, BMJ, vol.350, issue.jun15 14
DOI : 10.1136/bmj.h3029
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4468575

D. Brooker, L. Fontaine, J. Evans, S. Bray, J. Saad et al., Public health guidance to facilitate timely diagnosis of dementia: ALzheimer's COoperative Valuation in Europe recommendations, International Journal of Geriatric Psychiatry, vol.5, issue.1, pp.682-93, 2014.
DOI : 10.1002/gps.4066

G. Doblhammer, A. Fink, S. Zylla, and F. Willekens, Compression or expansion of dementia in Germany? An observational study of short-term trends in incidence and death rates of dementia between10 based on German health insurance data):66. 69. O'Loughlin C, darley J. Has the referral of older adults with dementia changed since the availability of acetylcholinesterase inhibitors and the NICE guidelines, Alzheimers Res Ther. Psychiatric Bullentin, vol.730, issue.1, pp.131-134, 2006.

D. Benson, R. Davis, B. Snyder, M. Lehmann, J. Schott et al., Posterior cortical atrophy Posterior cortical atrophy, Arch Neurol. Crutch SJ Lancet Neurol, vol.4511, issue.722, pp.789-93170, 1988.

J. Whitwell, C. Jack, . Jr, and K. Kantarci, Imaging correlates of posterior cortical atrophy, Neurobiology of Aging, vol.28, issue.7, pp.1051-61, 2007.
DOI : 10.1016/j.neurobiolaging.2006.05.026
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2734142

J. Renner, J. Burns, C. Hou, D. Mckeel, . Jr et al., Progressive posterior cortical dysfunction: a clinicopathologic series Clinical, genetic, and neuropathologic characteristics of posterior cortical atrophy, Neurology. Neurology, vol.6363, issue.757, pp.1175-11801168, 2004.

L. Souza, F. Corlier, and M. Habert, Similar amyloid-?? burden in posterior cortical atrophy and Alzheimer's disease, Brain, vol.134, issue.7, pp.2036-2043, 2011.
DOI : 10.1093/brain/awr130

H. Kivipelto and M. , Education and dementia: what lies behind the association? Neurology, 2007.

P. Rzezak, P. Squarzoni, and F. Duran, Relationship between Brain Age-Related Reduction in Gray Matter and Educational Attainment. PLoS One, 2015.
DOI : 10.1371/journal.pone.0140945
URL : http://doi.org/10.1371/journal.pone.0140945

J. Berkson, Limitations of the Application of Fourfold Table Analysis to Hospital Data, Biometrics Bulletin, vol.2, issue.3, pp.47-53, 1946.
DOI : 10.2307/3002000

S. Walter, Berkson's bias and its control in epidemiologic studies Smith GD, Ebrahim S. Data dredging, bias, or confounding, J Chronic Dis. BMJ, vol.33325, issue.877378, pp.11-12721, 1980.
DOI : 10.1016/0021-9681(80)90059-4

E. Herrett, S. Thomas, and L. Smeeth, Validity of diagnoses in the General Practice Research Database, British Journal of General Practice, vol.61, issue.588, pp.438-447, 2011.
DOI : 10.3399/bjgp11X583092

E. Birney, The making of ENCODE: Lessons for big-data projects, Nature, vol.489, issue.7414, pp.49-51, 2012.
DOI : 10.1038/489049a